Diabetes Mellitus (DM) Completed Phase 1 Trials for Metformin (DB00331)

Also known as: Diabetes Mellitus / Mellitus Diabetes / Diabetus Mellitus / Diabetes Mellitus (D003920) / Diabetes Mellitis / Diabetes mellitus (E08-E13) / Diabetes mellitus NOS / Diabetes

IndicationStatusPhase
DBCOND0063084 (Diabetes Mellitus (DM))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01192139Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
NCT01192152Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
NCT01775579Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin CalciumTreatment
NCT01929512Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mgTreatment
NCT02011633Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mgTreatment
NCT02026817Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mgTreatment
NCT02565862A Drug-drug Interaction Study Between Daclatasvir and Metformin